# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Ben Hendrix maintains Encompass Health (NYSE:EHC) with a Outperform and raises the price target from $83...
Raymond James analyst John Ransom reiterates Encompass Health (NYSE:EHC) with a Strong Buy and raises the price target from ...
Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $101 to...